Taipei, June 19 (CNA) Three scientists whose research laid the foundation for messenger RNA (mRNA) COVID-19 vaccines were named the winners of the 2022 Tang Prize in Biopharmaceutical Science, at a ceremony in Taipei on Sunday.
Taipei, June 19 (CNA) Taiwan will take delivery of 450,000 doses of the Moderna COVID-19 vaccine in early July and use them to supply up to 900,000 shots for children aged between 6 months and 5 years, according to the Central Epidemic Command Center (CECC).
Taipei, June 19 (CNA) The winners of the 2022 Tang Prize in Biopharmaceutical Science have credited curiosity, collaboration and finding joy in their work as critical to their efforts that laid the foundation for messenger RNA (mRNA) COVID-19 vaccines.
Three scientists whose research laid the foundation for messenger RNA (mRNA) COVID-19 vaccines were named the winners of the 2022 Tang Prize in Biopharmaceutical Science at a ceremony in Taipei yesterday.
Katalin Kariko, Drew Weissman and Pieter Cullis were recognized “for the discovery of key vaccinology concepts and approaches, leading to the successful development of mRNA-based COVID-19 vaccines,” the Tang Prize Foundation said.
The technologies developed by the three laureates “not only revolutionized vaccinology, but also signaled a paradigm shift in protein therapy. They represent the advent of a new era of RNA-based therapies,” the foundation said.
Kariko and Weissman, who have worked